KYLE LEFKOFF Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KYLE LEFKOFF.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KYLE LEFKOFF. KYLE LEFKOFF is in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in MIRAGEN THERAPEUTICS, INC. ($SGNL).
Latest Insider Trading Transactions of KYLE LEFKOFF
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 48.00 | 30,000 | 1,440,000 | 0 | 30 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 15,000 | 720,000 | 30,000 | 45 K to 30 K (-33.33 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 20,000 | 960,000 | 45,000 | 65 K to 45 K (-30.77 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 0.00 | 5,000 | 0 | 65,000 | 70 K to 65 K (-7.14 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 48.00 | 85 | 4,080 | 70,000 | 70.1 K to 70 K (-0.12 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 22,635 | 1,086,480 | 70,085 | 92.7 K to 70.1 K (-24.41 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 10.47 | 25,000 | 261,750 | 0 | ||
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 20.85 | 5,000 | 104,261 | 20,000 | 25 K to 20 K (-20.00 %) | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 20.82 | 5,000 | 104,121 | 25,000 | 30 K to 25 K (-16.67 %) | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 20.51 | 25,000 | 512,693 | 22,720 | 47.7 K to 22.7 K (-52.39 %) | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 10.47 | 25,000 | 261,750 | 47,720 | 22.7 K to 47.7 K (+110.04 %) | |
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | A | 14.55 | 25,000 | 363,750 | 25,000 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 0.00 | 5,000 | 0 | 22,720 | 17.7 K to 22.7 K (+28.22 %) | |
| Jul 06 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 5.95 | 25,000 | 148,750 | 0 | |
| Jul 06 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 5.13 | 25,000 | 128,250 | 0 | |
| Jul 06 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | S | 17.45 | 50,000 | 872,500 | 17,720 | 67.7 K to 17.7 K (-73.83 %) |
| Jul 06 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 5.95 | 25,000 | 148,750 | 67,720 | 42.7 K to 67.7 K (+58.52 %) |
| Jul 06 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 5.13 | 25,000 | 128,250 | 42,720 | 17.7 K to 42.7 K (+141.08 %) |
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 3.87 | 25,000 | 96,750 | 0 | ||
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 5.60 | 25,000 | 140,000 | 0 | ||
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 17.01 | 50,000 | 850,500 | 17,720 | 67.7 K to 17.7 K (-73.83 %) | |
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 3.87 | 25,000 | 96,750 | 67,720 | 42.7 K to 67.7 K (+58.52 %) | |
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 5.60 | 25,000 | 140,000 | 42,720 | 17.7 K to 42.7 K (+141.08 %) | |
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | A | 10.47 | 25,000 | 261,750 | 25,000 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 10.47 | 5,000 | 52,350 | 17,720 | 12.7 K to 17.7 K (+39.31 %) | |
| Sep 29 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 10.58 | 45,000 | 476,100 | 0 | ||
| Sep 29 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 12.31 | 38,865 | 478,428 | 12,720 | 51.6 K to 12.7 K (-75.34 %) | |
| Sep 29 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 10.58 | 45,000 | 476,100 | 51,585 | 6.6 K to 51.6 K (+683.37 %) | |
| Jun 30 2017 | MGEN | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Option Exercise | A | 12.06 | 12,000 | 144,720 | 12,000 | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 4.36 | 20,000 | 87,200 | 0 | ||
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 3.69 | 25,000 | 92,250 | 0 | ||
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 8.92 | 45,000 | 401,400 | 6,585 | 51.6 K to 6.6 K (-87.23 %) | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 4.36 | 20,000 | 87,200 | 51,585 | 31.6 K to 51.6 K (+63.32 %) | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 3.69 | 25,000 | 92,250 | 31,585 | 6.6 K to 31.6 K (+379.65 %) | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Gift | G | 0.00 | 2,000 | 0 | 6,585 | 8.6 K to 6.6 K (-23.30 %) | |
| Mar 13 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.31 | 3,300 | 47,229 | 463,473 | 466.8 K to 463.5 K (-0.71 %) |
| Mar 13 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.38 | 2,500 | 35,962 | 466,773 | 469.3 K to 466.8 K (-0.53 %) |
| Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.70 | 5,000 | 73,514 | 469,273 | 474.3 K to 469.3 K (-1.05 %) |
| Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 16.24 | 608 | 9,874 | 474,273 | 474.9 K to 474.3 K (-0.13 %) |
| Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 15.71 | 9,392 | 147,590 | 474,881 | 484.3 K to 474.9 K (-1.94 %) |
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.54 | 2,258 | 30,580 | 484,273 | 486.5 K to 484.3 K (-0.46 %) |
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.79 | 1,500 | 20,687 | 486,531 | 488 K to 486.5 K (-0.31 %) |
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.04 | 6,500 | 91,252 | 488,031 | 494.5 K to 488 K (-1.31 %) |
| Feb 24 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.65 | 1,800 | 24,566 | 494,531 | 496.3 K to 494.5 K (-0.36 %) |
| Feb 24 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.36 | 4,102 | 58,886 | 496,331 | 500.4 K to 496.3 K (-0.82 %) |
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | A | 5.95 | 25,000 | 148,750 | 25,000 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 5.83 | 5,000 | 29,150 | 8,585 | 3.6 K to 8.6 K (+139.47 %) | |
| Nov 02 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | A | 5.13 | 25,000 | 128,250 | 25,000 | ||
| Nov 02 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 2.46 | 20,000 | 49,200 | 0 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 3.51 | 20,000 | 70,200 | 0 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 1.74 | 15,000 | 26,100 | 0 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 3.37 | 15,000 | 50,550 | 0 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | S | 8.00 | 70,000 | 560,070 | 3,585 | 73.6 K to 3.6 K (-95.13 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 2.46 | 20,000 | 49,200 | 73,585 | 53.6 K to 73.6 K (+37.32 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 3.51 | 20,000 | 70,200 | 53,585 | 33.6 K to 53.6 K (+59.55 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 1.74 | 15,000 | 26,100 | 33,585 | 18.6 K to 33.6 K (+80.71 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 3.37 | 15,000 | 50,550 | 18,585 | 3.6 K to 18.6 K (+418.41 %) |
| Nov 03 2004 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | A | 7.21 | 30,000 | 216,300 | 30,000 |
Page: 1